comparemela.com

Page 3 - Sandra Herrmann News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biomarkers could help discriminate cancer therapy-associated kidney injury from other causes

Biomarkers could help discriminate cancer therapy-associated kidney injury from other causes A study by Mayo Clinic researchers published in Kidney International Reports finds that immune checkpoint inhibitors, may have negative consequences in some patients, including acute kidney inflammation, known as interstitial nephritis. Immune checkpoint inhibitors are used to treat cancer by stimulating the immune system to attack cancerous cells. Immune checkpoint inhibitors have improved the prognosis for patients with a wide range of malignancies including melanoma, non-small cell lung cancer and renal cancer. In some patients, this enhanced immune response may target kidney tissue, leading to acute kidney inflammation known as interstitial nephritis.

Role of Biomarkers In Assessing Renal Injury in Cancer Patients

Role of Biomarkers In Assessing Renal Injury in Cancer Patients by Angela Mohan on  February 4, 2021 at 11:03 AM Kidney International Reports. Immune checkpoint inhibitors have improved the prognosis for patients with a wide range of malignancies including melanoma, non-small cell lung cancer and renal cancer, says Sandra Herrmann, M.D., a Mayo Clinic nephrologist and the study s senior author. In some patients, this enhanced immune response may target kidney tissue, leading to acute kidney inflammation known as interstitial nephritis. Dr. Herrmann says a kidney biopsy is the gold standard to diagnose this condition. However, a kidney biopsy is an invasive procedure that some patients may not be able to undergo because of the risk of bleeding.

Study examines role of biomarkers to evaluate kidney injury in cancer patients undergoing immunotherapy

Date Time Study examines role of biomarkers to evaluate kidney injury in cancer patients undergoing immunotherapy A study by Mayo Clinic researchers published in Kidney International Reports finds that immune checkpoint inhibitors, may have negative consequences in some patients, including acute kidney inflammation, known as interstitial nephritis. Immune checkpoint inhibitors are used to treat cancer by stimulating the immune system to attack cancerous cells. “Immune checkpoint inhibitors have improved the prognosis for patients with a wide range of malignancies including melanoma, non-small cell lung cancer and renal cancer,” says Sandra Herrmann, M.D., a Mayo Clinic nephrologist and the study’s senior author. “In some patients, this enhanced immune response may target kidney tissue, leading to acute kidney inflammation known as interstitial nephritis.”

Dank für Einsatz gegen Covid-19

Dank für Einsatz gegen Covid-19
volksstimme.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from volksstimme.de Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.